Avoid These 8 Investing Horror Shows

Welcome, brave Fools, to our house of horror, where terrifying tales of investing frights rule the night.

In past years, we've celebrated Halloween by identifying the scariest stocks on the market, including a member of the living dead in the form of once-zombie bank Citigroup (NYSE: C  ) . We recounted the legendary ghost ship from the haunted sea, DryShips (Nasdaq: DRYS  ) . Since then the dry bulk carrier has claimed numerous victims, with its barrages of equity offerings that plundered existing shareholders' capital. And Fools were smart to heed our 2007 warnings about the creeping terror of Crocs (Nasdaq: CROX  ) , an investment that lost over 97% of its value in the next 12 months.

The 12 companies that made our list in 2009 certainly had a tumultuous year. Two, Palm and Diedrich Coffee, were gobbled up, by Hewlett-Packard and Green Mountain Coffee Roasters (Nasdaq: GMCR  ) , respectively. And another two, Fannie Mae and Freddie Mac were dishonorably delisted from the NYSE in July. Pfizer (NYSE: PFE  ) was stuck in neutral, Goldman Sachs and Research In Motion both lost 8%, and Dryships brought up the rear with a 31% drop. The only ones with market-beating performance were Baidu (Nasdaq: BIDU  ) , Sirius XM, and Crocs, with First Solar (Nasdaq: FSLR  ) coming in as roughly a market-perform.

This year we have a blood-curdling line-up that pays tribute to the B-movie monster flicks of the past, whose low budget scares frightened moviegoers. But those old films pale in comparison to the nightmares you'll see in this series. Each one of our full-length features highlights a unique story of financial peril, and unlike these B-movies, the shortcomings of our tales' targets won't grow endearing over time.

Read on and make sure to avoid these 8 investing horror shows:

The Investment That Wouldn't Die

How to Make a Monster Stock

Night of the Giant Money Leeches

Attack of the 50 P/E Stocks

Invasion of the One-Star Stocks

No One Is Safe From Killer Fees

Not-So-Little Shops of Horrors

Beware! This Amazing Colossal Mistake Could Eat Your Portfolio

Pfizer is a Motley Fool Inside Value pick. Baidu, First Solar, and Green Mountain Coffee Roasters are Motley Fool Rule Breakers choices. Try any of our Foolish newsletter services free for 30 days.

David Williamson owns shares of Pfizer. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool's disclosure policydoesn't know what's scarier, a meat dress or a Snuggie?


Read/Post Comments (1) | Recommend This Article (42)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 01, 2010, at 4:55 AM, tradingfurbo wrote:

    I agree. Let's try to find good performers for the nex years. I've RIMM wich seems to be cheap. Baidu wich seems to be a goog business for the next 20 years.

    Stryer Edu wich seem to be a good business and cheap.

    Try to buy good businesses not good stoks: it's quite different.

    Try to look at this:

    ****************

    http://www.tradingfurbo.net/analisi-tecnica-intuitiva/721/pa...

    ****************

    See you later aligator. :-)

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1350283, ~/Articles/ArticleHandler.aspx, 12/20/2014 4:07:09 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement